Saturday 17 October 2026
Export ABPO’s income statement to Excel — free account
Abpro Holdings Inc.
ABPO Healthcare Biotechnology
Abpro Holdings Inc.’s revenue for fiscal 2024 (year ended December 2024) was $183,000.00, up 50.0% from fiscal 2023. In the quarter to June 2026, EPS grew 89.3% and free cash flow was flat, each against the same quarter a year earlier.
0.36
0.05
−12.20%
Follow ABPO
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
Altman Z-Score |
— | (44.65) | (60.53) | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
— | (118.59) | (157.12) | — | — | — | — | — |
P/FCF ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
Beneish M-Score |
— | 0.02 | — | — | — | — | — | — |
P/Operating CF |
— | (10.98) | (34.30) | — | — | — | — | — |
P/B ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
Price to Tangible BV |
— | 0.00 | 0.00 | — | — | — | — | — |
EV/Sales |
— | 0.00 | 0.00 | — | — | — | — | — |
EV/EBITDA |
— | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | (4.31) | (27.20) | — | — | — | — | — |
EV/FCF |
— | (4.28) | (27.03) | — | — | — | — | — |
Quick Ratio |
0.03 | 0.16 | 0.06 | 0.18 | 0.18 | 0.00 | 0.00 | — |
Current Ratio |
0.10 | 0.19 | 0.13 | 0.36 | 0.36 | 0.00 | 0.00 | — |
Net Debt/EBITDA |
0.01 | 0.32 | 0.08 | 0.19 | 0.16 | — | (55.72) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 27.75% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.32 | — |
Asset Turnover |
0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
2.08 | 0.52 | 0.63 | (1.34) | (1.34) | — | 0.00 | — |
Capex/Depreciation |
0.04 | 0.00 | (0.06) | — | — | — | — | — |
Interest Coverage |
(7.49) | (25.64) | (510.70) | — | 0.00 | — | — | — |
| 24.90% | 33.68% | 23.50% | (15.90%) | 0.00% | 0.00% | 0.00% | — | |
| (101.05%) | (434.36%) | (7.46%) | 0.57% | 0.00% | 0.00% | (1.00%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
34.23% | 110.23% | 86.08% | (64.64%) | (64.64%) | 0.00% | 0.53% | — |
Average Days of Receivables |
0.00 | 365.00 | 263.28 | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 1,630.05% | 3,496.72% | — | — | — | — | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 3,891.26% | 6,231.15% | — | 0.00% | — | 0.00% | — |
Intangible Assets out of Total Assets |
0.16 | 0.04 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 1,053.01% | 1,889.34% | 0.00% | — | — | — | — |
Graham Net Nets |
— | (0.38) | (0.44) | — | — | — | — | — |
Graham Number |
— | 63.22 | 240.14 | — | — | — | — | — |
Earnings Yield |
— | (17.27%) | (5.82%) | — | — | — | — | — |
Free Cash Flow Yield |
— | (21.67%) | (3.68%) | — | — | — | — | — |
Revenue per Share |
0.00 | 0.23 | 0.19 | 0.00 | 0.00 | — | 0.00 | — |
Operating CF per Share |
(2.69) | (11.58) | (11.62) | (4.74) | (0.03) | — | 0.00 | — |
Capex per Share |
0.01 | 0.00 | (0.08) | 0.00 | 0.00 | — | 0.00 | — |
Free Cash Flow per Share |
(2.68) | (11.58) | (11.69) | (4.74) | (0.03) | — | 0.00 | — |
Cash per Share |
0.04 | 3.84 | 1.35 | 1.57 | 0.01 | — | 0.00 | — |
Shareholders Equity per Share |
(3.71) | (19.16) | (138.81) | (44.75) | 7.94 | 0.00 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Book value per Share |
(3.71) | (19.16) | (138.81) | (44.75) | 7.94 | 0.00 | 0.00 | — |
Free Cash Flow |
(5.98) | (9.03) | (7.45) | (1.18) | (1.18) | — | — | — |
Working Capital |
(8.45) | (15.83) | (13.70) | (1.37) | (1.37) | (0.34) | (0.34) | — |
Capital Expenditures |
0.03 | — | (0.05) | — | — | — | — | — |
Net Current Asset Value |
(8.45) | (15.83) | (89.75) | (320.97) | (11.87) | (0.34) | (0.34) | — |
EV/EBIT |
— | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.39 | — | — | — | — | — |
Price to Operating Income |
— | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.00 | 16.81 | 7.76 | — | — | — | — | — |
Cash ROIC |
72.93% | 75.54% | 8.51% | 10.99% | (0.40%) | 0.00% | 0.00% | — |
Accounts Receivable Turnover |
0.00 | 1.35 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Average Receivables |
0.18 | 0.14 | — | — | — | — | — | — |
Average Payables |
4.63 | 5.93 | 4.58 | — | — | — | — | — |
Average Assets |
2.86 | 4.01 | 156.96 | 155.46 | 155.46 | 0.36 | 0.18 | — |
Average Common Equity |
(11.61) | (51.69) | (49.81) | (5.58) | 148.97 | 0.02 | — | — |
Columns are period end dates